Key Insights

Highlights

Treatment Research

6 treatments under study, led by Epigallocatechin Gallate Control

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 100/100

Termination Rate

100.0%

1 terminated out of 1 trials

Success Rate

0.0%

-86.6% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

0

Data Visualizations

Phase Distribution

1Total
Not Applicable (1)

Trial Status

Terminated1

Clinical Trials (1)

Research Network

Common Treatments

  • Epigallocatechin Gallate Control1
  • Epigallocatechin Gallate1
  • Linoleic Acid Control1
  • Capsaicin Control1
  • Capsaicin Solution1

Active Sponsors

  • National Institutes Of Health Nih1
  • Purdue University1

Activity Timeline